Form 4: Cardlytics Director Liane Hornsey Acquires 11,000 Restricted Stock Units

Director Liane Hornsey acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024, which will vest in full on the one-year anniversary of the grant date.

Summary

• Liane Hornsey, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs) on May 23, 2024.
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided Hornsey remains a director at that time.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard compensation practice that aligns director interests with shareholders. There are no explicit negative implications.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs will vest in full on the one-year anniversary of the grant date, provided that the Reporting Person remains a director of the Issuer on such vesting date.

Industry Context

This is a standard practice for compensating and incentivizing board members in publicly traded companies.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice among publicly traded companies to align their interests with those of shareholders.
• The vesting schedule of one year is also fairly standard.
• Comparable companies in the technology and financial services sectors often use similar equity-based compensation plans for their directors.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates